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Key points:
Concern for the safety to the fetus is a commonly cited reason for vaccine refusal during
pregnancy. Results from this investigation support the safety of seasonal influenza
vaccination during pregnancy and suggest seasonal influenza vaccination may be protective
against stillbirth.
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Abstract

2

Background

3
4
5
6
7
8

Although antenatal influenza vaccination is an important public health intervention for
preventing serious infection in pregnant women and newborns, reported vaccine coverage is
often below 50%. Concern for the safety to the fetus is a commonly cited reason for vaccine
hesitancy and refusal. The incidence of stillbirth following pandemic vaccination has been
previously studied; however no population-based study has evaluated the incidence of
stillbirth following seasonal trivalent influenza vaccine (TIV).

9

Methods

10
11
12
13
14
15

We used probabilistic linking of perinatal and maternal vaccination records to establish a
cohort of 58,008 births occurring between April 2012 and December 2013. Stillbirth was
defined as birth ≥20 weeks gestation with an Apgar score of zero at one and five minutes
following delivery. Cox regression models adjusted for maternal smoking, Indigenous status
and propensity of vaccination were used to calculate adjusted hazard ratios (aHR) in
vaccinated and unvaccinated mothers.

16

Results

17
18
19
20
21
22

A total of 5,076 (8.8%) pregnant women received TIV and 377 stillbirths occurred. There were
5.0 and 3.0 stillbirths per 100,000 pregnancy days among unvaccinated and vaccinated
women, respectively. After adjustment, stillbirth was 51% less likely among vaccinated vs
unvaccinated mothers (aHR, 0.49; 95% confidence interval [CI], 0.29 to 0.84). The largest
relative reduction in stillbirths was observed for births occurring just after influenza season
(aHR, 0.33; 95% CI, 0.12 to 0.88).

23

Conclusions

24
25
26

Mothers who received seasonal TIV during pregnancy were significantly less likely to
experience stillbirth compared with unvaccinated mothers. These results support the safety of
seasonal influenza immunisation during pregnancy and suggest a protective effect.
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27

Background

28

Pregnant women are at increased risk of serious complications following influenza infection,

29

including pneumonia and acute respiratory distress syndrome.1–3 This increased risk is

30

thought to be the result of depressed cell-mediated immunity and physiological changes to the

31

cardiopulmonary system associated with pregnancy.1,3 Influenza infection during pregnancy

32

has also been linked to adverse fetal and neonatal outcomes, including increased risk of

33

preterm birth1,4 and fetal mortality; this effect has been most pronounced during influenza

34

pandemics.2,5,6 During the recent 2009 influenza A/H1N1 pandemic, a significant increase in

35

perinatal mortality was observed following maternal infection, most of this attributable to a

36

four-fold increase in stillbirths.5,7

37
38

Seasonal influenza vaccination has been shown to prevent infection in mothers and their

39

newborn infants,8,9 and the World Health Organization has indicated that pregnant women

40

should receive the highest priority for seasonal influenza vaccination.10 Reported vaccine

41

uptake remains below 50% in pregnant women, and concern regarding the safety of the

42

vaccine for the fetus is a commonly cited reason why women refuse vaccination.11–12

43

Enhanced data collection and surveillance during the 2009 H1N1 pandemic offered the unique

44

opportunity to monitor the safety of pandemic influenza vaccination in large, observational

45

studies.13 These studies suggested stillbirth was less common in women who received

46

pandemic vaccine compared to unvaccinated women, supporting the safety of pandemic

47

influenza vaccination during pregnancy;5,13–16 however, to date, no population-based study

48

has been conducted to evaluate the impact of antenatal administration of seasonal influenza

49

vaccination on stillbirth during non-pandemic influenza seasons.13,16 The aim of this study was

50

to assess the relative risk of stillbirth among vaccinated and unvaccinated pregnant women

51

during the 2012 and 2013 seasonal influenza epidemics in the winter months of the southern

52

hemisphere.
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53

Methods

54

Western Australia has a population of 2.4 million people, with 71% residing in the Perth

55

metropolitan area. There are approximately 30,000 births each year. For this analysis, multiple

56

state-wide data sources were linked by the Western Australian Data Linkage Branch of the

57

Western Australia Department of Health, using probabilistic matching of the full name and date

58

of birth of mothers who delivered in Western Australia between 1 April 2012 and 31 December

59

2013. The project was approved by the Western Australia Department of Health Human

60

Research Ethics Committee.

61

Data sources

62

Vaccination status

63

Seasonal trivalent influenza vaccine has been provided at no cost under the National

64

Immunisation Program to pregnant women since 2009 and has been part of routine antenatal

65

care in Western Australia since 2012. Post-partum surveys estimate that 25-36% of women

66

who were pregnant during the study period received seasonal trivalent influenza vaccine.17

67

The majority of pregnant women in Australia receive their influenza vaccine from general

68

practitioners; an additional 19% are immunised at public hospital antenatal clinics.17 As part

69

of ongoing vaccine safety surveillance, providers administering influenza vaccine during

70

pregnancy under the National Immunisation Program are asked to inform the Western

71

Australia Department of Health of the name, date of birth, and vaccination date of the

72

expectant mother. This information is stored in the Western Australia Antenatal Influenza

73

Vaccination Database. In our cohort, women with a vaccination record in the database with a

74

date of influenza vaccination occurring between the estimated date of conception (based on

75

gestation) and 14 days prior to date of delivery were defined as vaccinated during pregnancy.

76
77
78

Birth information
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79

The Midwives Notification System is a legally mandated data collection system which requires

80

the healthcare professional attending the birth to provide information at the time of delivery

81

related to the pregnancy for all births in Western Australia ≥20 weeks gestation.18 The midwife

82

in attendance usually submits birth information to the system; however, in the absence of a

83

midwife the medical officer is asked to submit the information. If there is no midwife or medical

84

officer in attendance, the first qualified midwife or medical offer to attend would submit the

85

information. In Western Australia, 98% of births occur in hospital (59% of which are public),

86

and 1% occur at a birth centre, all of which are staffed by midwives.18 The remaining 1% of

87

births occur at home, which may or may not be attended by a midwife. The Midwives

88

Notification System is thought to include 99% of births in the state.19 Midwives Notification

89

System data include the date of birth, birth weight, postcode of residence, status of the baby

90

at birth (alive or dead), Apgar scores at one and five minutes after delivery, medical conditions

91

of the mother, and complications related to the pregnancy and delivery. Gestation provided in

92

Midwives Notification System data is estimated based on a previously validated algorithm

93

drawing from both antenatal indicators (e.g. expected due date) and neonatal indicators of

94

gestation (e.g. sole creases, scalp hair).20 Stillbirth was defined as a birth where the infant was

95

recorded as stillborn by the clinician and had an Apgar score of zero at one minute and five

96

minutes following birth. This definition is consistent with previously published definitions.21

97

Maternal characteristics

98

Maternal age, pre-existing medical conditions, the occurrence of medical complications during

99

pregnancy (including pre-eclampsia, gestational diabetes, threatened abortion, threatened

100

preterm labour and urinary tract infections), and smoking during pregnancy (yes/no) were

101

obtained from the midwives’ records. Indigenous status was defined using a previously

102

validated algorithm drawing from multiple government administrative data sets.22 The

103

statistical local area of the mother at the time of birth was used to calculate a Socio-Economic

104

Indexes for Areas (SEIFA) score. Statistical local areas are Australian Standard Government

105

Classification defined local areas which cover the whole of Australia. SEIFA is comprised of
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106

several indices, the main index being that of relative disadvantage which is derived from low

107

income,

108

occupations.23 SEIFA scores were grouped into quintiles. Statistical local areas were also used

109

to assign individuals into levels of remoteness of their residence based on the Accessibility

110

and Remoteness Index (ARIA) scale, a national index developed by the National Centre for

111

Social Applications of Geographic Information Systems. ARIA scores are based on road

112

distance measurements from the statistical local area of residence to the nearest populated

113

locality greater than 1,000 persons; scores range from one (highly accessible) to five (highly

114

remote).24

115

Statistical analysis

116

The odds of vaccination and stillbirth were compared by maternal characteristics using

117

binomial logistic regression models. The odds of stillbirth were also compared by influenza

118

virus circulation at three time periods: pre-influenza season, influenza season, and post-

119

influenza season. Pre-influenza season was defined as 1 Apr - 3 Jun 2012 and 1 Jan - 14 Jul

120

2013; influenza season was defined as 4 Jun - 23 Sep 2012 and 15 Jul -13 Oct 2013; and

121

post-influenza season was defined as 24 Sep - 31 Dec 2012 and 14 Oct - 31 Dec 2013 (Figure

122

1). Seasonal cut-points were determined based on state-wide notifications for laboratory-

123

confirmed influenza during 2012 and 2013.

low

educational

attainment,

high

unemployment

and

jobs

in

unskilled

124
125

Similar to previous investigations,5,25–26 we used Cox regression models to compare the risk

126

of stillbirth in vaccinated and unvaccinated women. Days of gestation from 20 weeks was

127

included as the underlying time variable and vaccination status as the time-dependent

128

exposure variable. Because 62% of vaccinated women were immunised after 20 weeks of

129

pregnancy, i.e. during the observation period, vaccinated women contributed unvaccinated

130

person-time until their date of vaccination. Because influenza vaccine uptake was more

131

common in our cohort in women with higher risk pregnancies,17,21 models were adjusted by

132

propensity of vaccination to avoid potential confounding by indication. Propensity scores for
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133

vaccination were derived from a logistic regression model with maternal age, SEIFA and ARIA

134

scores, primiparity, multiple births, pre-existing medical conditions, and complications of

135

pregnancy as independent variables and vaccination status as the dependent variable.

136

Propensity scores ranged from -0.68 to 1.07 (median: 0.23, IQR: 0.05, 0.44). Models were

137

also adjusted for Indigenous status of the mother and self-reported smoking during pregnancy.

138
139

To estimate the effect in births following influenza season compared to the effect in births prior

140

to influenza season, we calculated a ratio of hazard ratios using the approach outlined by

141

Altman and Bland.27 Hazards regression models were also created to compare the risk of

142

stillbirth in preterm pregnancies (<37 weeks) and full-term pregnancies (≥37 weeks), and for

143

five levels of propensity for vaccination (strata 1, -0.69-0.01; strata 2, 0.02-0.15; strata 3, 0.16-

144

0.30; strata 4, 0.31-0.50; strata 5, 0.51-1.07). All covariates were tested to determine whether

145

models met the assumption of proportional hazards (α=.05).

146

Results

147

A total of 59,333 midwives records were provided for linkage with a date of birth from 1 April

148

2012 to 31 December 2013. Of these, 1,325 were excluded because the mother resided

149

outside of Western Australia (n=71) or had missing covariate information (n=1,254), leaving

150

58,008 births for analysis. A total of 5,541 births were linked to an influenza vaccination record

151

of which 5,076 (92%) had a date of administration 14 days or more prior to the date of delivery.

152

Therefore, the final dataset included 58,008 births, 5,076 to vaccinated mothers and 52,932

153

to unvaccinated mothers (Figure 2), contributing 7,716,084 days of follow-up during pregnancy

154

(462,808 days vaccinated and 7,253,276 days unvaccinated). The majority of births included

155

in the analysis were to mothers who were <35 years of age (80%), non-Indigenous (94%), and

156

in the top 20% socioeconomic (SEIFA) level (65%); 44% resided in a metropolitan area.

157

Influenza vaccination

Stillbirth and seasonal influenza vaccination during pregnancy, 7

158

Overall, 8.7% of the cohort received seasonal influenza vaccine during their pregnancy (6.9%

159

in 2012% and 10.2% in 2013). The proportion of births to vaccinated mothers ranged from

160

0.5% in April 2012 to 15.8% in August 2013, with the number of doses administered to

161

pregnant women peaking in April each year (Figure 1); 18.7% of vaccinated mothers were

162

immunised in the first 13 weeks of pregnancy; 45.7% were immunised in weeks 14 to 27 of

163

their pregnancy; and 35.6% were immunised in week 28 or later of pregnancy. Vaccination

164

was more common among women >35 years of age (odds ratio [OR], 1.08; 95% confidence

165

interval [CI], 1.01 to 1.15), women residing in highly accessible areas (OR, 2.17; 95% CI, 1.86

166

to 2.54), and women in the highest socioeconomic level (OR, 1.25; 95% CI, 1.09 to 1.45).

167

Women with pre-existing medical conditions were more likely to receive an influenza vaccine

168

(OR, 1.46; 95% CI, 1.38 to 1.54), as were women with pre-eclampsia (OR, 1.32; 95% CI, 1.11

169

to 1.57) or gestational diabetes (OR, 1.34; 95% CI, 1.21 to 1.48). Primiparous women and

170

women with multiple births were also more likely to be vaccinated compared to multiparous

171

and women with a singleton pregnancy (OR, 1.14; 95% CI, 1.07 to 1.21 and OR, 1.35; 95%

172

CI, 1.15 to 1.58, respectively) (Table 1).

173

Stillbirth

174

During the observation period, 377 stillbirths occurred, equating to 6.5 per 1,000 births overall.

175

Stillbirth was more common among women with diabetes (OR, 2.93; 95% CI, 1.44 to 5.93) or

176

hypertension (OR, 1.92; 95% CI, 1.92 to 5.88), women who smoked during pregnancy (OR,

177

1.42; 95% CI, 1.07 to 1.89), and Indigenous women (OR, 2.04; 95% CI, 1.47 to 2.83) (Table

178

2). Stillbirth was less common among women in the highest socioeconomic level (OR, 0.66;

179

95% CI, 0.44 to 0.99) and women residing in highly accessible areas (OR, 0.66; 95% CI, 0.46

180

to 0.97). Women with a multiple pregnancy had four times the odds of stillbirth compared to

181

women with a singleton pregnancy (OR, 4.08; 95% CI, 2.89 to 5.75). The majority (66.4%) of

182

stillbirths in the cohort occurred between 20 and 27 weeks gestation. Although not statistically

183

significant, stillbirth was more common during post-influenza season compared with pre-

184

influenza season (p=0.07) (Table 2).
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185
186

The unadjusted incidence of stillbirth in unvaccinated mothers was 5.0 per 100,000 pregnancy

187

days compared with 3.0 per 100,000 pregnancy days in vaccinated women (Table 3). The

188

adjusted risk of stillbirth was 51% lower among vaccinated women compared to unvaccinated

189

women (adjusted hazard ratio (aHR), 0.49; 95% CI, 0.29 to 0.84). Of the 465 women who

190

were vaccinated <14 days before the date of delivery, i.e. classified as unvaccinated for this

191

analysis, none had a stillbirth. When comparing the rate of stillbirth by gestational age, a

192

significant reduction in stillbirths among vaccinated mothers was only observed for stillbirths

193

occurring prior to 37 weeks of gestation (aHR, 0.45; 95% CI, 0.26 to 0.81). There was a non-

194

significant reduction in stillbirth associated with maternal influenza vaccination prior to the start

195

of the influenza season (aHR, 0.60; 95% CI, 0.22 to 1.61) and during the influenza season

196

(aHR, 0.57; 95% CI, 0.25 to 1.31); however, a greater and significant reduction was observed

197

for births occurring during the post-influenza season period (aHR, 0.33; 95% CI, 0.12 to 0.88)

198

(Figure 3). The ratio of hazards ratios during the post-influenza season period compared to

199

the pre-influenza season period was 0.55 (95% CI, 0.13 to 2.49), suggesting the effect of

200

vaccination may be greater following influenza season.

201

Discussion

202

To our knowledge, this is the first population-based study of seasonal trivalent influenza

203

vaccine and stillbirth, and the largest cohort study to date evaluating maternal vaccination and

204

stillbirth. We observed a reduced hazard of stillbirth associated with seasonal trivalent

205

influenza vaccine administered during pregnancy after controlling for risk factors for stillbirth

206

and accounting for factors associated with disproportionate uptake of maternal vaccination.

207

These results are consistent with those of previous large cohort studies investigating the

208

perinatal impact of pandemic and monovalent influenza vaccination in pregnancy13–16,26 and

209

support the safety of antenatal administration of seasonal trivalent influenza vaccine.

210
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211

Several findings in our study support an association between influenza infection and stillbirth.

212

The observed rate of stillbirth was higher following periods of influenza virus circulation (e.g.

213

November through December) compared to periods prior to influenza season (e.g. January

214

through May). Although seasonal differences were not statistically significant (p=0.07), these

215

results suggest a possible temporal association between stillbirth and influenza season.

216

Researchers in Finland observed seasonal patterns in the population incidence of stillbirth,

217

with the highest rates of stillbirth occurring just after influenza season in the northern

218

hemisphere (March) and the lowest rates in summer and autumn.28 Furthermore, the effect

219

estimate between vaccination and stillbirth was greater during the post-influenza season

220

period compared to the pre-influenza season period. Additional studies should further evaluate

221

the possible temporal association between stillbirth and influenza season.

222
223

Our results are consistent with those of previous large cohort studies of maternal influenza

224

vaccination during an influenza pandemic.13–15,26 Although observational cohort studies, such

225

as ours, are subject to potential bias, including uncontrolled confounding due to the nature of

226

the study design,13 there are several strengths to this large observational cohort study. First,

227

observational cohort studies are the most efficient method of measuring the impact of maternal

228

influenza vaccination on stillbirth, given the relatively low incidence of stillbirth in developed

229

countries and potentially low uptake of vaccine.13 With an incidence of 6.4 stillbirths per 1,000

230

births in Australia,29 other study designs such as randomised controlled trials would be

231

implausible, as well as unethical, given that maternal influenza vaccination is now

232

recommended as standard of care. Second, previous observational, cohort studies have taken

233

measures to prevent uncontrolled confounding, including propensity score adjustment26 and

234

controlling for known maternal risk factors,15 and have observed a significant protective effect

235

of maternal vaccination. Similar to these investigations, we stratified our analyses by the

236

mother’s propensity for vaccination and adjusted for known maternal risk factors for stillbirth.

237

Regardless of maternal risk factors and differing predisposition to vaccination, stillbirth was

238

significantly less common in vaccinated mothers compared to unvaccinated.
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239
240

Despite the strengths of this cohort study, there are several limitations to our cohort which

241

should be considered. Measurement of vaccination status in this cohort is thought to have

242

been incomplete. In the absence of a registry of adult vaccinations in Australia, we relied on

243

provider-reported vaccination events and there was no legal requirement to report these

244

vaccinations. An evaluation of the completeness of reporting for maternal influenza

245

vaccinations in Western Australia found that approximately half (46%) get reported to the state

246

vaccination database.30 In addition, a post-partum survey of mothers in Western Australia who

247

delivered in April through October in 2012 and 2013 indicated that 26% and 36% (respectively)

248

had received an influenza vaccination during the study period.17 In our cohort, 9% and 14% of

249

mothers were reportedly immunised during these respective time periods. However, because

250

false positives (i.e. reporting a vaccination when one did not occur) are very unlikely in the

251

vaccination database,30 exposure misclassification in our cohort would likely bias our results

252

toward the null, indicating the protective effect between vaccinations and stillbirths that we

253

observed may be an underestimate of the true effect measure. Second, our cohort was

254

restricted to the Australian setting over two influenza seasons; therefore our results may not

255

be generalizable to developing countries, where stillbirth is more common, or influenza

256

seasons for which the protection afforded by the vaccine might be different. Finally, due to low

257

number of outcomes in our dataset, we were unable to compare the safety of seasonal

258

influenza vaccine by trimester of administration. Future research should examine whether the

259

lower incidence of stillbirth associated with antenatal influenza vaccinations we observed is

260

applicable to other influenza seasons and settings and across trimesters of vaccine

261

administration.

262

Conclusions

263

Our results support the safety of maternal influenza vaccination, as we found no increase in

264

the risk of stillbirth in vaccinated women. Additional research is needed to confirm the potential

265

reduction in stillbirth observed in this cohort study. There are over three million stillborn infants
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266

each year worldwide, and in developed countries stillbirth accounts for 70% of perinatal

267

deaths;31 confirmation of these findings would indicate seasonal influenza vaccination in

268

pregnancy has substantial perinatal health benefits. These results may be useful for

269

communicating the potential benefits of seasonal influenza vaccination to pregnant mothers

270

and their providers. Given the growing body of evidence supporting the health benefits to

271

mother and infant, concerted efforts are needed to improve seasonal influenza vaccine

272

coverage among pregnant women.
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Table 1. Antenatal influenza vaccination status of women who delivered in
Western Australia between 1 April 2012 and 31 December 2013, by
demographic characteristics and obstetric history.*

Characteristic

Percent vaccinated

Vaccinated versus
Unvaccinated

Maternal age

n

% (95% CI)

OR (95% CI)*

<35 years

3,987

8.6 (8.4-8.9)

Ref

≥35 years

1,089

9.2 (8.7-9.8)

1.08 (1.01-1.15) †

Indigenous

317

9.6 (8.7-10.7)

Ref

Non-Indigenous

4,759

8.7 (8.5-8.9)

0.89 (0.79-1.01)

Quintile 1 (most disadvantaged)

227

7.1 (6.2-8.0)

Ref

Quintile 2

754

8.1 (7.6-8.7)

1.16 (0.99-1.35)

Quintile 3

612

7.7 (7.2-8.3)

1.10 (0.94-1.29)

Quintile 4

1,701

9.9 (9.5-10.3)

1.44 (1.25-1.66) †

Quintile 5 (least disadvantaged)

1,782

8.7 (8.3-9.1)

1.25 (1.09-1.45) †

Very remote

177

4.9 (4.2-5.7)

Ref

Remote

126

8.0 (6.8-9.5)

1.69 (1.33-2.14)‡

Moderately accessible

357

7.4 (6.7-8.2)

1.55 (1.29-1.87) ‡

Accessible

1,855

8.2 (7.8-8.6)

1.73 (1.48-2.03 ‡

Highly accessible

2,561

10.1 (9.7-10.5)

2.17 (1.86-2.54)‡

No

5,014

8.7 (8.5-8.9)

Ref

Yes

62

14.3 (11.4-18.0)

1.76 (1.34-2.30)‡

Indigenous status

Socioeconomic status (SEIFA)

Remoteness of residence (ARIA)

Pre-existing diabetes

Essential hypertension
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No

5,005

8.7 (8.5-8.9)

Ref

Yes

71

11.5 (9.2-14.2)

1.36 (1.06-1.74)‡

No

4,477

8.6 (8.4-8.8)

Ref

Yes

599

10.1 (9.4-10.9)

1.20 (1.10-1.31)‡

No

4,520

8.8 (8.5-9.0)

Ref

Yes

556

8.6 (7.9-9.3)

0.98 (0.89-1.07)

No

4,087

8.4 (8.2-8.7)

Ref

Yes

989

10.5 (9.9-11.2)

1.29 (1.19-1.38)‡

Singleton

4,902

8.7 (8.5-8.9)

Ref

Multiple

174

11.3 (9.8-13.0)

1.35 (1.15-1.58) ‡

Multiparous

3,352

8.4 (8.2-8.7)

Ref

Primiparous

1,724

9.5 (9.0-9.9)

1.14 (1.07-1.21) ‡

Asthma

Smoked during pregnancy

Complications during pregnancy§

Type of delivery

Parity

*Shown

are the odds of vaccination by select demographic and medical characteristics of mothers as calculated by

unconditional logistic regression models.
†Significant at α=.05
‡Significant

at α=.01

§ Complications

during pregnancy included pre-eclampsia, gestational diabetes, threatened preterm abortion, threatened

preterm labour, and urinary tract infections.
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Table 2. Stillbirths recorded in Western Australia between 1 April 2012 and
31 December 2013, by maternal characteristics.*
Stillbirth vs live
birth

Characteristic

Stillbirths per 1,000 pregnancies

Maternal age

n

No. per 1,000 (95% CI)

OR (95% CI)*

<35 years

295

6.4 (5.7-7.2)

Ref

≥35 years

82

6.9 (5.5-8.6)

1.09 (0.85-1.39)

Indigenous

41

12.5 (9.0-16.9)

Ref

Non-Indigenous

336

6.1 (5.5-6.8)

2.04 (1.47-2.83)†

Quintile 1 (most disadvantaged)

29

9.1 (6.3-13.0)

Ref

Quintile 2

64

6.9 (5.4-8.8)

0.76 (0.49-1.18)

Quintile 3

49

6.2 (4.7-8.2)

0.68 (0.43-1.08)

Quintile 4

112

6.5 (5.4-7.8)

0.72 (0.48-1.08)

Quintile 5 (least disadvantaged)

123

6.0 (5.0-7.2)

0.66 (0.44-0.99) †

Very remote

34

9.4 (6.8-13.1)

Ref

Remote

13

8.3 (4.8-14.1)

0.88 (0.46-1.67)

Moderately accessible

28

5.8 (4.0-8.4)

0.62 (0.37-1.02)

Accessible

142

6.3 (5.3-7.4)

0.66 (0.45-0.97)‡

Highly accessible

160

6.3 (5.4-7.4)

0.66 (0.46-0.97)‡

No

369

6.4 (5.8-7.1)

Ref

Yes

8

18.5 (9.4-36.1)

2.93 (1.44-5.93) ‡

Indigenous status

Socioeconomic status (SEIFA)

Remoteness of residence (ARIA)

Pre-existing diabetes

Essential hypertension
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No

364

6.3 (5.7-7.0)

Ref

Yes

13

21.0 (12.3-35.6)

3.36 (1.92-5.88) ‡

No

344

6.6 (5.9-7.3)

Ref

Yes

33

5.6 (4.0-7.8)

0.85 (0.59-1.21)

No

320

6.2 (5.6-6.9)

Ref

Yes

57

8.8 (6.8-11.4)

1.42 (1.07-1.89) ‡

No

308

6.3 (5.7-7.1)

Ref

Yes

69

7.4 (5.8-9.3)

1.16 (0.90-1.51)

Singleton

340

6.0 (5.4-6.7)

Ref

Multiple

37

24.1 (17.5-33.1)

4.08 (2.89-5.75)‡

Multiparous

257

6.5 (5.7-7.3)

Ref

Primiparous

120

6.6 (5.5-7.9)

1.02 (0.82-1.27)

Pre-season

147

6.2 (5.2-7.2)

Ref

Within season

111

6.1 (5.0-7.3)

0.99 (0.77-1.26)

Post-season

119

7.5 (6.3-9.0)

1.22 (0.95-1.55)

Asthma

Smoked during pregnancy

Complications during pregnancy

Type of delivery

Parity

Influenza season

*Shown

are the odds of stillbirth by select demographic and medical characteristics of mothers as calculated by unconditional

logistic regression models.
†Significant at α=.05
‡Significant

at α=.01

§ Complications

during pregnancy included pre-eclampsia, gestational diabetes, threatened preterm abortion, threatened

preterm labour, and urinary tract infections.

Stillbirth and seasonal influenza vaccination during pregnancy, 17

Table 3. Hazard ratio of stillbirth, by maternal influenza vaccination status*
Vaccinated
(n=5,076)

Unvaccinated
(n=52,932)

Stillbirths per
100,000
pregnancy days

Stillbirths per
100,000
pregnancy days

Unadjusted

Adjusted†

3.0

5.0

0.52 (0.31-0.91)§

0.49 (0.29-0.84)§

at <37 weeks

32.8

67.8

0.43 (0.24-0.77)§

0.45 (0.26-0.81)§

at ≥37 weeks

0.5

0.6

1.20 (0.29-4.97)

1.13 (0.27-4.71)

-0.69-0.01

1.6

3.4

0.39 (0.05-2.79)

0.36 (0.05-2.60)

0.02-0.15

3.7

4.6

0.72 (0.23-2.29)

0.68 (0.21-2.18)

0.16-0.30

3.5

4.1

0.74 (0.23-2.38)

0.74 (0.23-2.38)

0.31-0.50

2.9

6.3

0.41 (0.13-1.30)

0.41 (0.13-1.29)

0.51-1.07

3.2

6.7

0.41 (0.15-1.13)

0.40 (0.15-1.10)

TOTAL

Hazard Ratio (95% CI)*

By gestation

By propensity for influenza vaccination§§

*

Listed are the incidence and hazard of stillbirth compared by seasonal influenza vaccination status in mothers as

calculated based on Cox regression models.
†

Adjusted analyses controlled for maternal smoking, Indigenous status, and propensity for vaccination.

§

Significant at α=.01

¶

Significant at α=.05

§§

Propensity scores were calculated based on maternal age, SEIFA and ARIA score, primiparity, multiple birth, pre-

existing medical conditions, and complications of pregnancy as in Table 1.
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Figure 1. Weekly distribution of live and stillbirths, doses of seasonal
trivalent influenza vaccine and laboratory-confirmed influenza cases
during cohort study period.

Figure 2. Data linkage of birth cohort – Western Australia, Australia, 201213.

Figure 3. Hazard ratio of stillbirth, by seasonal influenza activity*
Figure 3 footnotes:
*Depicted are the hazard ratios of stillbirth in mothers who had trivalent influenza
vaccination compare to unvaccinated mother during pre-influenza, influenza, and
post-influenza periods as calculated based on Cox regression models.
†Hazard

ratios were calculated using Cox regression models which adjusted for maternal smoking,

Indigenous status, and propensity for vaccination.
§ Influenza

season was defined based on state-wide laboratory-confirmed influenza notifications. Pre-

influenza season included births occurring between 01Apr2012-03Jun2012 and 01Jan201314Jul2013, influenza season included births occurring between 04Jun2012-23Sep2012 and
15Jul2013-13Oct2013, and post-influenza season included births occurring between 24Sep201231Dec2012 and 14Oct2013-31Dec2013.
¶ Significant

at α=.01.
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